BRAINprofiler

Scientific Background References for the BRAINprofiler

1. Settle, S.H. & Sulman, E.P. Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment. Curr Oncol Rep 13, 26-36 (2011).

2. Sulman, E.P. & Aldape, K. The use of global profiling in biomarker development for gliomas. Brain Pathol 21, 88-95 (2011).

3. Reifenberger, G. & Louis, D.N. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J. Neuropathol. Exp. Neurol 62, 111-126 (2003).

4. Blesa, D. e.a. Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma. J. Neuropathol. Exp. Neurol 68, 274-285 (2009).

5. Ney, D.E. & Lassman, A.B. Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions. Curr Oncol Rep 11, 62-67 (2009).

6. Gravendeel, L.A.M. e.a. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 69, 9065-9072 (2009).

7. Kros, J.M. e.a. Intratumoral distribution of 1p loss in oligodendroglial tumors. J. Neuropathol. Exp. Neurol 66, 1118-1123 (2007).

8. Bralten, L.B.C. e.a. Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene. Genes Chromosomes Cancer 49, 509-517 (2010).

9. French, P.J. e.a. Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res 67, 5635-5642 (2007).

10. Watson, M.A. e.a. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas. Cancer Res 61, 1825-1829 (2001).

11. Huang, H. e.a. Gene expression profiling and subgroup identification of oligodendrogliomas. Oncogene 23, 6012-6022 (2004).

12. French, P.J. e.a. Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res 65, 11335-11344 (2005).